Vorschau: EBSIN_Winter_2025_DD services

European Biotechnology Winter 2025

© Dec022024 - stock.adobe.com

Drug delivery services

Preview Winter 2025

SPECIAL

Publication date: 11 December, 2025

Drug delivery services Hot topics in drug delivery Although smart drug delivery accounts for only 10% of drug development costs, significant efforts have been made to optimise drug properties such as solubility, stability and release kinetics, while developing strategies to overcome biological barriers and improve drug delivery to the target site, thereby minimising off-target toxicities. In the next generation of drug delivery solutions, AI-driven nanorobots will recognise physiological microenvironments to deliver targeted medicines, promising to expand the therapeutic index of inherently toxic modalities. The latest drug delivery solutions as well as automated analysis tools, sensors, and AI/ ML approaches to data modelling will be presented in this special feature. Become visible in European Bio­ technology’s CDMO & CRO special feature and present your offering or portfolio to customers.

Present your expertise Biomedical engineers, drug developers, CDMOs, formulation experts, AI experts and medical device engineers have the opportunity to showcase their latest products, services and developments in this special feature. European Biotechnology Magazine is distributed to decision makers across the European life sciences sector and through our official partner, SLAS, in the USA. Take advantage of the magazine’s highly relevant readership and use this opportunity to reach your target audience!

Topics to be covered Services & equipment: Nanoparticles & vesicles, carbon nanotubes, organotropic bacteria/viruses, sustained release formulations, thin film delivery, drug carriers, CDMROs, excipients, brain shuttles & neural drug delivery systems, nanocapsules, gene delivery systems, experimental therapeutics, regulatory affairs, hydrogels, nasal administration, multispecific drug targeting vehicles, intracellular delivery, robotic pills, self-administration.

Editorial Deadline 26-11-2025

Booking Deadline 28-11-2025

Publication Date 11-12-2025

Editorial contact: Thomas Gabrielczyk Tel.: +49-30-264921-50 Fax: +49-30-264921-11 t.gabrielczyk@biocom.de

Marketing contact: Oliver Schnell Tel.: +49-30-264921-45 Fax: +49-30-264921-11 o.schnell@biocom.de

Marketing contact: Andreas Macht Tel.: +49-30-264921-54 Fax: +49-30-264921-11 a.macht@biocom.de

BIOCOM Interrelations GmbH I Jacobsenweg 61 I 13509 Berlin I www.biocom.de

Special: Drug Delivery Services

Meet your audience!

European Biotechnology is published in co-operation with the following organisations: European Biotechnology Net work

Young European Biotech Network

Europe: european-biotechnology.net

Europe: yebn.eu

Austria: lifescienceaustria.at

Austria: biotechaustria.org

United States: slas.org

Europe: medicinesforeurope.com

Ireland: ibec.ie/ibia

Denmark: danskbiotek.dk

The Netherlands: hollandbio.nl

Germany: gasb.de

Portugal: www.p-bio.org

UK: biopartner.co.uk

France: france-biotech.org

Italy: assobiotec.federchimica.it

Sweden: swedenbio.com

Hungary: hungarianbiotech.org

Europe: cebr.net

Spain: asebio.com

Norway: bioteknologiradet.no

Finland: suomenbioteollisuus.fi

Belgium: bio.be

Switzerland: swissbiotech.org

European Biotechnology covers the biotechnology sector of the current 27 EU member states, Norway, Switzerland, and UK. If you would like to subscribe, please refer to european-biotechnology.com